![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Real-World Assessment of Renal and Bone Safety Among Patients Exposed to
Tenofovir Disoproxil Fumarate-Containing Single Tablet Regimens
|
|
|
Reported by Jules Levin
Presented at: ASM Microbe 2016, June 16-20, 2016, Boston, MA
Ella Nkhoma, PhD;1 Lisa Rosenblatt, MD, MPH;2 Joel Myers, MPharm;2 John Coumbis, MD, MPH;3
1Bristol-Myers Squibb, Wallingford, CT, USA; 2Bristol Myers Squibb, Plainsboro, NJ, USA; 3Bristol Myers Squibb, Hopewell, NJ, USA.
Among patients prescribed STRs, significant risk factors for fracture identified on
univariate analysis were older age and a history of substance abuse (Figure 2)
![HIV1](../images/093016/093016-1/HIV1.gif)
![HIV2](../images/093016/093016-1/HIV2.gif)
![HIV3](../images/093016/093016-1/HIV3.gif)
![HIV4](../images/093016/093016-1/HIV4.gif)
![HIV5](../images/093016/093016-1/HIV5.gif)
![HIV6](../images/093016/093016-1/HIV6.gif)
![HIV7](../images/093016/093016-1/HIV7.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|